Literature DB >> 6287557

The production in culture of metalloproteinases and an inhibitor by joint tissues from normal rabbits, and from rabbits with a model arthritis. I. Synovium.

G J Cambray, G Murphy, D P Page-Thomas, J J Reynolds.   

Abstract

During 5 days of culture, explants of normal rabbit synovium produced no active collagenase, negligible latent collagenase, but significant levels of free collagenase inhibitor. Synovium from joints exhibiting a proliferative arthritis produced greatly elevated levels of collagenase; the appearance of active enzyme in the medium during the second day of culture was associated with the disappearance of free inhibitor. Enzyme levels in the media correlated well with the arthritic status of joints, when explants were prepared up to 10 weeks after the induction of the model arthritis. Synovium from the contralateral joints of rabbits with unilaterally induced arthritis produced no active collagenase, but approximately one-third as much latent collagenase as found with arthritic joints. Enzymatic activities against gelatin and cartilage proteoglycan substrates were demonstrated in synovial culture media in addition to collagenolytic activity. Gel filtration showed that these activities were not due to a single enzyme, and further characterisation confirmed that the enzymes were metalloproteinases. The results are considered in the light of published data, and the involvement of metalloproteinases and their specific inhibitor in the development of arthritic lesions is discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6287557     DOI: 10.1007/bf00541217

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  23 in total

1.  Collagenolytic activity of synovium in rheumatoid arthritis.

Authors:  G S Lazarus; J L Decker; C H Oliver; J R Daniels; C V Multz; H M Fullmer
Journal:  N Engl J Med       Date:  1968-10-24       Impact factor: 91.245

2.  Evidence that latent collagenases are enzyme-inhibitor complexes.

Authors:  A Sellers; E Cartwright; G Murphy; J J Reynolds
Journal:  Biochem J       Date:  1977-05-01       Impact factor: 3.857

3.  Neutral metallo-proteinases of rabbit bone. Separation in latent forms of distinct enzymes that when activated degrade collagen, gelatin and proteoglycans.

Authors:  A Sellers; J J Reynolds; M C Meikle
Journal:  Biochem J       Date:  1978-05-01       Impact factor: 3.857

4.  Proteoglycan-degrading enzymes. A radiochemical assay method and the detection of a new enzyme cathepsin F.

Authors:  J T Dingle; A M Blow; A J Barrett; P E Martin
Journal:  Biochem J       Date:  1977-12-01       Impact factor: 3.857

Review 5.  Collagenases (first of three parts).

Authors:  E D Harris; S M Krane
Journal:  N Engl J Med       Date:  1974-09-12       Impact factor: 91.245

6.  Liposome-incorporated corticosteroids. II. Therapeutic activity in experimental arthritis.

Authors:  N C Phillips; D P Thomas; C G Knight; J T Dingle
Journal:  Ann Rheum Dis       Date:  1979-12       Impact factor: 19.103

7.  A new factor that may control collagen resorption.

Authors:  J J Reynolds; G Murphy; A Sellers; E Cartwright
Journal:  Lancet       Date:  1977-08-13       Impact factor: 79.321

8.  Production of collagenase and prostaglandins by isolated adherent rheumatoid synovial cells.

Authors:  J M Dayer; S M Krane; R G Russell; D R Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  1976-03       Impact factor: 11.205

9.  Electron microscopic observations of immunoreactive cells in the rheumatoid synovial membrane.

Authors:  H Ishikawa; M Ziff
Journal:  Arthritis Rheum       Date:  1976 Jan-Feb

10.  Monitoring of experimental arthritis in rabbits.

Authors:  N C Phillips; D P Page-Thomas
Journal:  Ann Rheum Dis       Date:  1979-02       Impact factor: 19.103

View more
  8 in total

1.  Metalloproteinases from rabbit bone culture medium degrade types IV and V collagens, laminin and fibronectin.

Authors:  G Murphy; T E Cawston; W A Galloway; M J Barnes; R A Bunning; E Mercer; J J Reynolds; R E Burgeson
Journal:  Biochem J       Date:  1981-12-01       Impact factor: 3.857

2.  The effects of cytokines on metalloproteinase inhibitors (TIMP) and collagenase production by human chondrocytes and TIMP production by synovial cells and endothelial cells.

Authors:  M Shingu; Y Nagai; T Isayama; T Naono; M Nobunaga; Y Nagai
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

3.  The cartilage-resorbing protein catabolin is made by synovial fibroblasts and its production is increased by phorbol myristate acetate.

Authors:  L M Pilsworth; J Saklatvala
Journal:  Biochem J       Date:  1983-11-15       Impact factor: 3.857

4.  The effects of dexamethasone in vitro on the production of collagenase and inhibitor by synovial and cartilage explants from the joints of rabbits with a proliferative arthritis.

Authors:  G J Cambray; G Murphy; J J Reynolds
Journal:  Rheumatol Int       Date:  1981       Impact factor: 2.631

5.  The production in culture of metalloproteinases and an inhibitor by joint tissues from normal rabbits, and from rabbits with a model arthritis. II. Articular cartilage.

Authors:  G Murphy; G J Cambray; N Virani; D P Page-Thomas; J J Reynolds
Journal:  Rheumatol Int       Date:  1981       Impact factor: 2.631

6.  Rabbit models of arthritis: immunolocalization of matrix metalloproteinases and tissue inhibitor of metalloproteinase in synovium and cartilage.

Authors:  R M Hembry; M R Bagga; G Murphy; B Henderson; J J Reynolds
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

7.  Blockade of integrin VLA-4 prevents inflammation and matrix metalloproteinase expression in a murine model of accelerated collagen-induced arthritis.

Authors:  Anil Raychaudhuri; Mary Chou; Marla Weetall; Arco Y Jeng
Journal:  Inflammation       Date:  2003-04       Impact factor: 4.092

8.  Isolation and characterization of an inhibitor of neovascularization from scapular chondrocytes.

Authors:  M A Moses; J Sudhalter; R Langer
Journal:  J Cell Biol       Date:  1992-10       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.